Research Areas
Discover how patient-derived organoids can be applied throughout the oncology drug development pipeline, demonstrated in colorectal cancer research.
Discover how patient-derived organoids can be applied throughout the oncology drug development pipeline, demonstrated in colorectal cancer research.
| 4 min read
A first-in-human trial shows how computationally designed antigens could help shift vaccines from reactive to future-proof.
| 3 min read
The MHRA-led sandbox will generate real-world evidence on AI tools that could improve medicines safety, reduce late-stage failures, and accelerate drug development.
| 4 min read
Microbubble-based genetic medicines, pharma deals, trial misses, and more led the news this week.
| 4 min read
As drug discovery adopts more human-relevant models and complex biologics, it’s increasingly important that reagents are more consistent, better characterized, and fit for purpose.
Explore how 3D bioprinting is helping researchers create more realistic cancer models for studying tumor behavior, therapy response, and treatment resistance.
Learn how stability profiling and biophysical characterization support biologics candidate selection, formulation, and preclinical development.
| 6 min read
Long framed as a gynecological condition, PMOS is now understood as a multisystem disorder with metabolic, psychological, and cardiovascular consequences.
| 7 min read
As gene editing advances, legacy off-target screening approaches are struggling to keep pace with increasing biological and regulatory complexity.
Popular Topics
Multimedia
Discover practical strategies to improve pipetting accuracy, reproducibility, ergonomics, and instrument performance across diverse laboratory workflows.
Learn how patient-derived tumor organoids, AI, and phenotypic screening are advancing the discovery of small molecule therapeutics.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
